Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2674-2692
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2674
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2674
Figure 2 Empirical antimicrobial approach of abdominal post-surgical infections.
CPE: Carbapenem-resistant Enterobacterales; C/T: Ceftolozane/tazobactam; CZA: Ceftazidime/avibactam; DAP: Daptomycin; I-R: Imipenem-relebactam; LVX: Levofloxacin; LNZ: Linezolid; MDR: Multidrug-resistance; MRSA: Methicillin-resistant Staphylococcus aureus; MTZ: Metronidazole; MVB: Meropenem-vaborbactam; TZP: Piperacillin-tazobactam; VAN: Vancomycin; VRE: Vancomycin-resistant Enterococci.
- Citation: Fiore M, Corrente A, Di Franco S, Alfieri A, Pace MC, Martora F, Petrou S, Mauriello C, Leone S. Antimicrobial approach of abdominal post-surgical infections. World J Gastrointest Surg 2023; 15(12): 2674-2692
- URL: https://www.wjgnet.com/1948-9366/full/v15/i12/2674.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i12.2674